VEGFB and Parkinson disease: This study by Falk et al. involved utilizing a mildly progressive unilateral 6-hydroxydopamine (OHDA) rat PD model with an intrastriatal injection of VEGF-B prior to the neurotoxic 6-OHDA treatment.